Across TCGA pan-cancer cohorts, DAZAP2 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated DAZAP2 data layer compared with 21 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher DAZAP2 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated DAZAP2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CCRCC show a favorable association.

UCEC, HNSC, and CCRCC are the cancer types where DAZAP2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Quartile	All	0.847	1.000	.005	22	view →
HNSC	DFS	Tertile	III,IV	0.810	0.185	.006	18	view →
CCRCC	OS	Median	IV	1.000	0.202	.034	11	view →
PDAC	OS	Median	II,III,IV	0.744	0.892	.017	9	view →
GBM	DFS	Quartile	All	0.426	0.279	.035	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: DAZAP2 tumor-vs-normal RNA expression · all DAZAP2 data types